On Friday, InspireMD Inc (NYSEMKT:NSPR)’s shares declined -0.05% to $0.200.
InspireMD, Inc. ( NSPR) a leader in embolic protection systems, declared recently that it will release its full financial results for the second quarter ended June 30, 2015 on Wednesday, August 5th after the market close, followed by a conference call at 4:30 p.m. ET to review its financial results and update key planned partnership programs.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing PVGuard for use in peripheral vascular applications.
Ecolab Inc. (NYSE:ECL)’s shares dropped -1.54% to $109.53.
Ecolab will host a live webcast of its earnings conference call to talk about second quarter results and future earnings guidance. A news release containing second quarter results and future earnings guidance is predictable to be issued before market open on July 28, 2015.
Ecolab Inc. provides water, hygiene, and energy technologies and services for customers worldwide. The company operates in four segments: Global Industrial, Global Institutional, Global Energy, and Other.
At the end of Friday’s trade, Teradata Corporation (NYSE:TDC)‘s shares dipped -2.29% to $35.87.
Teradata ( TDC), the big data analytics and marketing applications company, launched the next-generation Teradata Appliance for Hadoop®, version 5, which is configurable, ready-to-run and offers a choice of the latest version of Hadoop from Hortonworks® (HDP™ 2.3), and for the first time, Cloudera (Cloudera Enterprise 5.4). This appliance gives users the flexibility to accelerate time-to-value and reduce Hadoop cost of ownership.
Teradata’s new appliance helps resolve challenges that some companies have in implementing Hadoop, providing faster time-to-market with a fully-engineered, enterprise-class solution – one that reduces total cost of ownership while facilitating integration with the Teradata® Unified Data Architecture™ (UDA), a framework for organizations to address all types of data and multiple Teradata systems.
Teradata Corporation provides analytic data platforms, marketing and analytic applications, and related services in the United States and internationally. Its analytic data platforms comprise software, hardware, and related business consulting and support services for data warehousing and big data analytics.
Cardiovascular Systems Inc (NASDAQ:CSII), ended its Friday’s trading session with -6.11% loss, and closed at $30.33.
Cardiovascular Systems, Inc. (CSI) will host a live webcast of its fiscal 2015 fourth-quarter conference call on Wednesday, August 5, 2015, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will talk about the company’s results for its fiscal fourth quarter ended June 30, 2015, and its financial outlook. The company will issue a post-market earnings release preceding to the call on August 5.
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and markets devices for the treatment of vascular diseases. Its products comprise catheter-based platforms, such as the Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
